RANEXA 1000 MG

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
RANOLAZINE 1000 MG
Available from:
NEOPHARM LTD
ATC code:
C01EB18
Pharmaceutical form:
TABLETS EXTENDED RELEASE
Administration route:
PER OS
Manufactured by:
CV THERAPEUTICS INC, USA
Therapeutic group:
RANOLAZINE
Therapeutic indications:
Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
Authorization number:
144543294600
Authorization date:
2010-10-01

Similar products

Search alerts related to this product

Share this information